Second-line therapies in immune thrombocytopenia. [electronic resource]
- Hematology. American Society of Hematology. Education Program Dec 2016
- 698-706 p. digital
Publication Type: Journal Article; Review
1520-4383
10.1182/asheducation-2016.1.698 doi
Adult Costs and Cost Analysis Hemorrhage--blood Humans Immunoglobulins, Intravenous--economics Purpura, Thrombocytopenic, Idiopathic--blood Quality of Life Rho(D) Immune Globulin--economics Risk Factors